Suppr超能文献

评价两种用于检测阴道样本中无乳链球菌的快速商业检测方法。

Evaluation of two rapid commercial assays for detection of Streptococcus agalactiae from vaginal samples.

机构信息

Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.

Division of Obstetrics, University Hospital of Zurich, Zurich, Switzerland.

出版信息

Acta Obstet Gynecol Scand. 2023 Apr;102(4):450-456. doi: 10.1111/aogs.14519. Epub 2023 Feb 11.

Abstract

INTRODUCTION

Streptococcus agalactiae, also known as group B streptococci (GBS), is associated with invasive infections in neonates. Identification of GBS vaginal colonization in pregnant women before delivery is essential for treatment with antibiotics to prevent intrapartum vertical transmission to the newborn. This study was designed to evaluate applicability of two rapid real-time PCRs in comparison to standard culture identification.

MATERIAL AND METHODS

We compared the Xpert GBS assay, hereafter referred to as Xpert, and GenomEra GBS PCR, hereafter referred to as GenomEra. The standard culture identification consisted of two different agar plates as well as an enrichment broth.

RESULTS

We analyzed vaginal samples of 260 pregnant women; 42 samples were tested GBS-positive by using standard culture as a gold standard, 30 by Xpert, and 37 by GenomEra. Xpert and GenomEra assays performed with sensitivities of 71.4% and 88.1% as well as specificities of 98.6% and 99.1%, respectively. Twelve vaginal samples were false-negative by Xpert and five samples by GenomEra. Interestingly, three negative Xpert results of standard culture-positive samples exhibited high Ct-values indicating the presence of GBS. If higher Ct-values are taken into consideration, the sensitivity of Xpert increases up to 78.6%. Moreover, only three Xpert PCRs had to be repeated, whereas two Genomera were invalid even after repetition and further 15 GenomEra PCRs were repeated because of borderline results or inhibition of the PCR test.

CONCLUSIONS

In this study, GenomEra assay performed with a higher sensitivity than the Xpert PCR. On the other hand, the Xpert assay needs less hands-on-time for a sample preparation and requires approximately four-fold less repetitions as compared to the GenomEra assay. This robust performance of the Xpert assay make it applicable as a rapid intrapartum point-of-care test, although a higher sensitivity would be desirable. Therefore, culture in the 35-37 week of gestation remains the gold standard to detect vaginal colonization.

摘要

简介

无乳链球菌又称 B 群链球菌(GBS),与新生儿侵袭性感染有关。在分娩前确定孕妇的 GBS 阴道定植情况对于用抗生素进行治疗以防止产时垂直传播给新生儿至关重要。本研究旨在评估两种快速实时 PCR 与标准培养鉴定相比的适用性。

材料和方法

我们比较了 Xpert GBS 检测(简称 Xpert)和 GenomEra GBS PCR(简称 GenomEra)。标准培养鉴定包括两种不同的琼脂平板以及一种增菌肉汤。

结果

我们分析了 260 名孕妇的阴道样本;42 份样本经标准培养鉴定为 GBS 阳性,30 份样本经 Xpert 鉴定为 GBS 阳性,37 份样本经 GenomEra 鉴定为 GBS 阳性。Xpert 和 GenomEra 检测的灵敏度分别为 71.4%和 88.1%,特异性分别为 98.6%和 99.1%。Xpert 有 12 份阴道样本检测结果为假阴性,GenomEra 有 5 份阴道样本检测结果为假阴性。有趣的是,3 份标准培养阳性但 Xpert 结果为阴性的样本的 Ct 值较高,表明存在 GBS。如果考虑较高的 Ct 值,Xpert 的灵敏度可提高至 78.6%。此外,仅需要重复进行 3 次 Xpert PCR,而重复两次后仍无效的 GenomEra 检测有 2 次,进一步有 15 次 GenomEra PCR 由于结果临界或 PCR 检测受到抑制而需要重复。

结论

在本研究中,GenomEra 检测的灵敏度高于 Xpert PCR。另一方面,与 GenomEra 检测相比,Xpert 检测在样本制备方面需要更少的人工操作时间,并且需要的重复次数大约少四倍。尽管更高的灵敏度是理想的,但 Xpert 检测的稳健性能使其适用于快速的产时即时护理检测。因此,妊娠 35-37 周时的培养仍然是检测阴道定植的金标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7d3/10008276/1a4e1dfcd00e/AOGS-102-450-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验